MS therapy alemtuzumab is named a ‘rip-off’ drug, report

Pharmaceutical companies sell some MS disease modifying therapies (DMTs) at extortionate prices. Big pharma stands accused of setting prices to rip-off the public, and the UK’s National Health Service (NHS). Who’d have thought it? I am shocked (well, no, not really). One such drug labelled a rip-off, and used to treat multiple sclerosis, is alemtuzumab. It … Continue reading MS therapy alemtuzumab is named a ‘rip-off’ drug, report